Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis

Clinical trial NCT07403370 · COMPLETED

Trial details

NCT number: NCT07403370
Sponsor: Shandong Cancer Hospital and Institute
Status: COMPLETED
Study type: OBSERVATIONAL

Solid Tumours Olanzapine Nausea and Vomiting

Start date: 2026-01-18
Primary completion: 2026-02-15
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.